Factors Relating To Iron Defiiency Anemia In Pr...

Acetaminophen And The Pain Management In Cesare...

Effects Of Use Of Interceed Barrier At Primary ...

Factors Related To Thrombotic Microangiopathies...

Retrospective Database Analysis Of Clinical Out...

0 votes
Effects Of Use Of Interceed Barrier At Primary Cs On Repeat Cs
Author: Hector O Chapa, Gonzalo Venegas
6 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
ISBN/ISSN: 1178-7082
DOI: 10.2147/41447
Follow this publisher

Share this publication:


Objective: The aim of this study was to compare maternal morbidity at repeat cesarean section (CS) between use of a Gynecare Interceed™ Absorbable Adhesion Barrier (Gynecare, Somerville, NJ, USA) and non-use at primary cesarean delivery.

Design: This was a retrospective study of patients in whom an absorbable adhesion barrier was/was not used at their primary CS.

Methods: Mean and excessive blood loss, the need for adhesiolysis, and postoperative fever were compared between those in whom a barrier was used at first CS and those in whom a barrier was not used. Visceral injury at repeat cesarean was also compared between the two groups.

Results: No statistically significant difference in mean blood loss was noted between the two groups. However, significantly more patients in whom a barrier was not used had excessive intraoperative blood loss (barrier group, 1/53 [1.9%]; no-barrier group, 6/59 [10.1%]; P = 0.04). All seven cases of excessive blood loss had adhesiolysis. Significantly more patients in the no-barrier group underwent adhesiolysis (no-barrier group, 35/59 [59.3%]; barrier group, 7/53 [13.2%]; P = 0.03). No statistical difference in postoperative metritis was noted (1/59 [1.8%] in the barrier group and 1/59 [1.7%] in the no-barrier group; P = 0.99). Only one deserosalization of the bladder dome occurred in a patient in the no-barrier group.

Conclusion: Those in whom a barrier was not used at primary CS were more likely to have adhesiolysis and excessive blood loss (.1250 mL) at repeat CS. No significant difference in postoperative metritis/fever was noted between groups. Adhesion barrier at primary CS may reduce some aspects of maternal morbidity at repeat CS.

Select a payment method